Filing Details

Accession Number:
0001144204-16-140572
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-20 20:44:44
Reporting Period:
2016-12-16
Filing Date:
2016-12-20
Accepted Time:
2016-12-20 20:44:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1208261 Immune Pharmaceuticals Inc IMNP Pharmaceutical Preparations (2834) 521841431
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1589342 Daniel Kazado C/O Immune Pharmaceuticals Inc.
430 East 29Th Street, Suite 940
New York NY 10016
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-16 161,377 $0.19 1,068,667 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Restricted shares issued for payment of accrued fees for board services issued at a conversion price equal to the closing price of the Company's common stock on the date immediately preceding the date that the Company's board of directors approved such conversion.